4D Advisors LLC boosted its stake in shares of Axon Enterprise, Inc (NASDAQ:AXON - Free Report) by 6.7% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 16,000 shares of the biotechnology company's stock after buying an additional 1,000 shares during the period. Axon Enterprise comprises 6.5% of 4D Advisors LLC's investment portfolio, making the stock its 2nd largest holding. 4D Advisors LLC's holdings in Axon Enterprise were worth $8,415,000 as of its most recent filing with the Securities and Exchange Commission.
Several other institutional investors and hedge funds have also recently bought and sold shares of AXON. Brighton Jones LLC acquired a new stake in Axon Enterprise during the 4th quarter worth about $480,000. AQR Capital Management LLC increased its holdings in shares of Axon Enterprise by 382.2% in the 4th quarter. AQR Capital Management LLC now owns 23,363 shares of the biotechnology company's stock valued at $13,885,000 after purchasing an additional 18,518 shares during the period. Mercer Global Advisors Inc. ADV increased its holdings in shares of Axon Enterprise by 19.5% in the 4th quarter. Mercer Global Advisors Inc. ADV now owns 5,448 shares of the biotechnology company's stock valued at $3,238,000 after purchasing an additional 889 shares during the period. Aptus Capital Advisors LLC acquired a new position in shares of Axon Enterprise in the 4th quarter valued at about $445,000. Finally, Baker Avenue Asset Management LP acquired a new position in shares of Axon Enterprise in the 4th quarter valued at about $255,000. Institutional investors and hedge funds own 79.08% of the company's stock.
Analysts Set New Price Targets
A number of brokerages have recently weighed in on AXON. UBS Group reiterated a "neutral" rating and issued a $840.00 target price (up previously from $820.00) on shares of Axon Enterprise in a report on Tuesday, August 5th. JMP Securities upped their target price on Axon Enterprise from $725.00 to $825.00 and gave the company a "market outperform" rating in a report on Tuesday, July 22nd. Northland Securities set a $800.00 target price on Axon Enterprise in a report on Tuesday, August 5th. JPMorgan Chase & Co. upped their target price on Axon Enterprise from $730.00 to $850.00 and gave the company an "overweight" rating in a report on Thursday, July 17th. Finally, Wolfe Research began coverage on Axon Enterprise in a report on Monday, July 7th. They issued an "outperform" rating on the stock. Thirteen analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company's stock. According to data from MarketBeat.com, Axon Enterprise currently has an average rating of "Moderate Buy" and a consensus price target of $837.69.
Check Out Our Latest Stock Analysis on Axon Enterprise
Axon Enterprise Trading Down 4.4%
NASDAQ:AXON opened at $747.29 on Tuesday. The stock's 50 day moving average price is $771.42 and its 200 day moving average price is $677.75. Axon Enterprise, Inc has a 52 week low of $346.71 and a 52 week high of $885.91. The company has a market capitalization of $58.66 billion, a P/E ratio of 184.52, a P/E/G ratio of 27.43 and a beta of 1.40. The company has a debt-to-equity ratio of 0.63, a quick ratio of 2.71 and a current ratio of 2.95.
Axon Enterprise (NASDAQ:AXON - Get Free Report) last released its quarterly earnings data on Monday, August 4th. The biotechnology company reported $2.12 EPS for the quarter, topping analysts' consensus estimates of $1.54 by $0.58. Axon Enterprise had a return on equity of 6.80% and a net margin of 13.64%.The firm had revenue of $668.54 million for the quarter, compared to the consensus estimate of $641.77 million. During the same quarter in the prior year, the company posted $1.20 earnings per share. The firm's revenue was up 32.6% on a year-over-year basis. Axon Enterprise has set its FY 2025 guidance at EPS. On average, research analysts forecast that Axon Enterprise, Inc will post 5.8 EPS for the current fiscal year.
Insider Activity
In other Axon Enterprise news, CAO Jennifer H. Mak sold 75 shares of the company's stock in a transaction that occurred on Friday, June 13th. The stock was sold at an average price of $771.81, for a total transaction of $57,885.75. Following the completion of the sale, the chief accounting officer owned 15,240 shares of the company's stock, valued at $11,762,384.40. This represents a 0.49% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Patrick W. Smith sold 10,000 shares of the company's stock in a transaction that occurred on Monday, August 11th. The stock was sold at an average price of $831.29, for a total value of $8,312,900.00. Following the sale, the chief executive officer directly owned 3,053,982 shares of the company's stock, valued at $2,538,744,696.78. The trade was a 0.33% decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 40,703 shares of company stock valued at $31,366,051. Insiders own 5.70% of the company's stock.
Axon Enterprise Profile
(
Free Report)
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Axon Enterprise, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Axon Enterprise wasn't on the list.
While Axon Enterprise currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here

We are about to experience the greatest A.I. boom in stock market history...
Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.
That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.
- The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
- The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
- Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.
Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.
And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...
Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.